These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2354118)

  • 21. Plasma and suction blister fluid levels of etretinate and its main metabolite during treatment of psoriasis.
    Lauharanta J; Paravicini U
    Arch Dermatol Res; 1982; 272(1-2):147-9. PubMed ID: 6219628
    [No Abstract]   [Full Text] [Related]  

  • 22. Reduced levels of histidine and urocanic acid in suction blister fluids from patients with psoriasis.
    Juhlin L; Shroot B; Martin B; Caron JC
    Acta Derm Venereol; 1986; 66(4):295-300. PubMed ID: 2430398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of tumor necrosis factor-alpha in suction blister fluids and stratum corneum from patients with psoriasis.
    Takematsu H; Ohta H; Tagami H
    Arch Dermatol Res; 1989; 281(6):398-400. PubMed ID: 2596867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetical studies on cyclosporin A in psoriasis.
    Meinardi MM; van Boxtel CJ; Oosting J; Dos JD
    Acta Derm Venereol Suppl (Stockh); 1989; 146():164. PubMed ID: 2532845
    [No Abstract]   [Full Text] [Related]  

  • 25. Availability of synthetic salmon calcitonin in tissue fluid after a single intravenous dose.
    Concia E; Cruciani M; Bartucci F; Arrigoni L; Longoni A
    Eur J Clin Pharmacol; 1994; 46(4):371-3. PubMed ID: 7957525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kidney biopsies in control or cyclosporin A-treated psoriatic patients. International Kidney Biopsy Registry of Cyclosporin A (Sandimmun) in Autoimmune Diseases.
    Br J Dermatol; 1990 Jun; 122 Suppl 36():95-100. PubMed ID: 2369573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal function after long-term low-dose cyclosporin for psoriasis.
    Powles AV; Carmichael D; Hulme B; Thomas E; McFadden J; Baker B; Valdimarsson H; Fry L
    Br J Dermatol; 1990 May; 122(5):665-9. PubMed ID: 2112945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skin tissue fluid levels of cefotiam in healthy man following oral cefotiam hexetil.
    Korting HC; Schäfer-Korting M; Kees F; Lukacs A; Grobecker H
    Eur J Clin Pharmacol; 1990; 39(1):33-6. PubMed ID: 2276386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained renal function loss in psoriasis patients after withdrawal of low-dose cyclosporin therapy.
    Korstanje MJ; Bilo HJ; Stoof TJ
    Br J Dermatol; 1992 Nov; 127(5):501-4. PubMed ID: 1467290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-10 levels are decreased in psoriatic lesional skin as compared to the psoriatic lesion-free and normal skin suction blister fluids.
    Mussi A; Bonifati C; Carducci M; Viola M; Tomaselli R; Sacerdoti G; Fazio M; Ameglio F
    J Biol Regul Homeost Agents; 1994; 8(4):117-20. PubMed ID: 7660853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative pharmacokinetics of 8-MOP in serum and in suction blister fluid.
    Reymond JL; Beani JC; Racinet H; Bonnot D; Beriel H; Amblard P
    Photodermatol; 1988 Feb; 5(1):51-2. PubMed ID: 3353318
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyclosporin trough levels: is monitoring necessary during short-term treatment in psoriasis? A systematic review and clinical data on trough levels.
    Heydendael VM; Spuls PI; Ten Berge IJ; Opmeer BC; Bos JD; de Rie MA
    Br J Dermatol; 2002 Jul; 147(1):122-9. PubMed ID: 12100194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporin A: preliminary results in the treatment of psoriasis.
    Bonifati C; Clerico R; Potenza CM; Carlesimo M
    Acta Derm Venereol Suppl (Stockh); 1989; 146():151-4. PubMed ID: 2532844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of low-dose cyclosporin A in psoriasis: results of dose-finding studies.
    Timonen P; Friend D; Abeywickrama K; Laburte C; von Graffenried B; Feutren G
    Br J Dermatol; 1990 Jun; 122 Suppl 36():33-9. PubMed ID: 2196082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of cyclosporin A pharmacokinetics of a new microemulsion formulation and standard oral preparation in patients with psoriasis.
    Erkko P; Granlund H; Nuutinen M; Reitamo S
    Br J Dermatol; 1997 Jan; 136(1):82-8. PubMed ID: 9039300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporin A in combination with photochemotherapy (PUVA) in the treatment of psoriasis.
    Petzelbauer P; Hönigsmann H; Langer K; Anegg B; Strohal R; Tanew A; Wolff K
    Br J Dermatol; 1990 Nov; 123(5):641-7. PubMed ID: 2248892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of oral cyclosporin A (CyA; Sandimmun) for long-term treatment of chronic severe plaque psoriasis.
    Laburte C; Grossman R; Abi-Rached J; Abeywickrama KH; Dubertret L
    Br J Dermatol; 1994 Mar; 130(3):366-75. PubMed ID: 8148280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ketoconazole concentrations in human skin blister fluid and plasma.
    Schäfer-Korting M; Korting HC; Dorn M; Mutschler E
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):371-4. PubMed ID: 6088407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-1-beta, interleukin-6, and interferon-gamma in suction blister fluids of involved and uninolved skin and in sera of psoriatic patients.
    Bonifati C; Ameglio F; Carducci M; Sacerdoti G; Pietravalle M; Fazio M
    Acta Derm Venereol Suppl (Stockh); 1994; 186():23-4. PubMed ID: 8073828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of cyclosporin in psoriasis.
    Bos JD; Meinardi MM; van Joost T; Heule F; Powles AV; Fry L
    Lancet; 1989 Dec 23-30; 2(8678-8679):1500-2. PubMed ID: 2574777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.